Highlights:
We review four long recommendations that have struggled in recent weeks.
COHR has actually kept pace with the market since April, but with enormous volatility. Investors are swinging between cyclical concerns and secular optimism.
FTCH is now our worst pick ever — but we’re not yet willing to give up on a complicated story.
Accuray’s turnaround …